Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 1
1991 1
1992 2
1993 1
1995 1
1996 1
1999 1
2000 1
2008 2
2010 1
2011 2
2012 3
2013 2
2016 3
2017 4
2018 2
2020 4
2021 7
2022 4
2023 4
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Results by year

Filters applied: . Clear all
Page 1
Prognostic Factors across Poorly Differentiated Neuroendocrine Neoplasms: A Pooled Analysis.
Centonze G, Maisonneuve P, Prinzi N, Pusceddu S, Albarello L, Pisa E, Barberis M, Vanoli A, Spaggiari P, Bossi P, Cattaneo L, Sabella G, Solcia E, La Rosa S, Grillo F, Tagliabue G, Scarpa A, Papotti M, Volante M, Mangogna A, Del Gobbo A, Ferrero S, Rolli L, Roca E, Bercich L, Benvenuti M, Messerini L, Inzani F, Pruneri G, Busico A, Perrone F, Tamborini E, Pellegrinelli A, Kankava K, Berruti A, Pastorino U, Fazio N, Sessa F, Capella C, Rindi G, Milione M. Centonze G, et al. Among authors: pisa e. Neuroendocrinology. 2023;113(4):457-469. doi: 10.1159/000528186. Epub 2022 Nov 23. Neuroendocrinology. 2023. PMID: 36417840 Free article.
Predictive Markers of Response to Everolimus and Sunitinib in Neuroendocrine Tumors.
Martins D, Spada F, Lambrescu I, Rubino M, Cella C, Gibelli B, Grana C, Ribero D, Bertani E, Ravizza D, Bonomo G, Funicelli L, Pisa E, Zerini D, Fazio N; IEO ENETS Center of Excellence for GEP NETs. Martins D, et al. Among authors: pisa e. Target Oncol. 2017 Oct;12(5):611-622. doi: 10.1007/s11523-017-0506-5. Target Oncol. 2017. PMID: 28634872 Review.
Multimodal treatment for resectable neuroendocrine carcinoma of the cervix.
Valenza C, Spada F, Multinu F, Benini L, Borghesani M, Algeri L, Rubino M, Pisa E, Gervaso L, Cella CA, Carinelli S, Bruni S, Schivardi G, Curigliano G, Zanagnolo V, Aletti G, Colombo N, Fazio N. Valenza C, et al. Among authors: pisa e. Endocr Relat Cancer. 2023 Aug 14;30(10):e230112. doi: 10.1530/ERC-23-0112. Print 2023 Oct 1. Endocr Relat Cancer. 2023. PMID: 37428640
We retrospectively examined data from patients with non-metastatic NECC candidate to receive surgery and (neo)adjuvant chemotherapy and discussed at the European Institute of Oncology's Multidisciplinary Neuroendocrine Tumor Board, between January 2003 and December …
We retrospectively examined data from patients with non-metastatic NECC candidate to receive surgery and (neo)adjuvant chemotherapy and disc …
Can Ki-67 predict radiotherapy response in neuroendocrine tumors? Retrospective analysis of a monocentric series of patients.
Zerini D, Rotondi M, Volpe S, Pisa E, Frigo E, Pedone C, Flospergher M, Bagnardi V, Frassoni S, Fodor CI, Spada F, Fazio N, Alterio D, Jereczek-Fossa BA. Zerini D, et al. Among authors: pisa e. Tumori. 2023 Oct;109(5):504-510. doi: 10.1177/03008916231160587. Epub 2023 Mar 20. Tumori. 2023. PMID: 36942401
BACKGROUND: The impact of radiotherapy (RT) in neuroendocrine neoplasms is still unknown, and outcomes could be improved by a better insight in RT response predictors. ...
BACKGROUND: The impact of radiotherapy (RT) in neuroendocrine neoplasms is still unknown, and outcomes could be improved by a better …
Metronomic and metronomic-like therapies in neuroendocrine tumors - Rationale and clinical perspectives.
Lambrescu I, Fica S, Martins D, Spada F, Cella C, Bertani E, Rubino M, Gibelli B, Grana C, Bonomo G, Funicelli L, Ravizza D, Pisa E, Zerini D, Ungaro A, Fazio N; IEO ENETS Center of Excellence for GEP NET. Lambrescu I, et al. Among authors: pisa e. Cancer Treat Rev. 2017 Apr;55:46-56. doi: 10.1016/j.ctrv.2017.02.007. Epub 2017 Feb 24. Cancer Treat Rev. 2017. PMID: 28314176 Review.
Metronomic schedule is usually correlated with chemotherapy in oncology, but other therapies, such as radiotherapy and biotherapy can be delivered in a metronomic like manner. ...
Metronomic schedule is usually correlated with chemotherapy in oncology, but other therapies, such as radiotherapy and biotherapy can …
The role of multimodal treatment in patients with advanced lung neuroendocrine tumors.
Fazio N, Ungaro A, Spada F, Cella CA, Pisa E, Barberis M, Grana C, Zerini D, Bertani E, Ribero D, Funicelli L, Bonomo G, Ravizza D, Guarize J, De Marinis F, Petrella F, Del Signore E, Pelosi G, Spaggiari L. Fazio N, et al. Among authors: pisa e. J Thorac Dis. 2017 Nov;9(Suppl 15):S1501-S1510. doi: 10.21037/jtd.2017.06.14. J Thorac Dis. 2017. PMID: 29201453 Free PMC article. Review.
They represent the well differentiated (WD) or low/intermediate grade forms of lung neuroendocrine neoplasms (NENs). Unlike the lung poorly differentiated NENs, that are usually treated with chemotherapy, lung NETs can be managed with several different therapies, making a …
They represent the well differentiated (WD) or low/intermediate grade forms of lung neuroendocrine neoplasms (NENs). Unlike the lung …
A single-institution retrospective analysis of metachronous and synchronous metastatic bronchial neuroendocrine tumors.
Peri M, Botteri E, Pisa E, De Marinis F, Ungaro A, Spada F, Grana CM, Gasparri R, Spaggiari L, Romentz N, Badalamenti G, Russo A, Fazio N. Peri M, et al. Among authors: pisa e. J Thorac Dis. 2018 Jul;10(7):3928-3939. doi: 10.21037/jtd.2018.06.78. J Thorac Dis. 2018. PMID: 30174834 Free PMC article.
METHODS: Clinical records of patients with a cytological or histological diagnosis of bpNETs and distant metastases (metachronous or synchronous), evaluated at the European Institute of Oncology between 1997 and 2014, were retrospectively analyzed. Data on patient demograp …
METHODS: Clinical records of patients with a cytological or histological diagnosis of bpNETs and distant metastases (metachronous or synchro …
Lung carcinoids with high proliferative activity: Further support for the identification of a new tumor category in the classification of lung neuroendocrine neoplasms.
Rubino M, Scoazec JY, Pisa E, Faron M, Spaggiari L, Hadoux J, Spada F, Planchard D, Cella CA, Leboulleux S, De Marinis F, Ducreux M, Lamartina L, Baudin E, Fazio N. Rubino M, et al. Among authors: pisa e. Lung Cancer. 2020 Oct;148:149-158. doi: 10.1016/j.lungcan.2020.08.001. Epub 2020 Aug 8. Lung Cancer. 2020. PMID: 32916569
OBJECTIVES: Clinical and pathological data of 630 patients with lung carcinoids (LC) referred to Gustave Roussy Institute (GR) and European Institute of Oncology (IEO) were retrospectively reviewed to select HPLC and analyze their frequency, behavior and compare the …
OBJECTIVES: Clinical and pathological data of 630 patients with lung carcinoids (LC) referred to Gustave Roussy Institute (GR) and European …
Automated Analysis of Proliferating Cells Spatial Organisation Predicts Prognosis in Lung Neuroendocrine Neoplasms.
Bulloni M, Sandrini G, Stacchiotti I, Barberis M, Calabrese F, Carvalho L, Fontanini G, Alì G, Fortarezza F, Hofman P, Hofman V, Kern I, Maiorano E, Maragliano R, Marchiori D, Metovic J, Papotti M, Pezzuto F, Pisa E, Remmelink M, Serio G, Marzullo A, Trabucco SMR, Pennella A, De Palma A, Marulli G, Fassina A, Maffeis V, Nesi G, Naheed S, Rea F, Ottensmeier CH, Sessa F, Uccella S, Pelosi G, Pattini L. Bulloni M, et al. Among authors: pisa e. Cancers (Basel). 2021 Sep 29;13(19):4875. doi: 10.3390/cancers13194875. Cancers (Basel). 2021. PMID: 34638359 Free PMC article.
Lung neuroendocrine neoplasms (lung NENs) are categorised by morphology, defining a classification sometimes unable to reflect ultimate clinical outcome. ...
Lung neuroendocrine neoplasms (lung NENs) are categorised by morphology, defining a classification sometimes unable to reflect ultima …
Prognostic features of gastro-entero-pancreatic neuroendocrine neoplasms in primary and metastatic sites: Grade, mesenteric tumour deposits and emerging novelties.
Kankava K, Maisonneuve P, Mangogna A, Centonze G, Cattaneo L, Prinzi N, Pusceddu S, Fazio N, Pisa E, Di Domenico S, Bertani E, Mazzaferro V, Albertelli M, Grillo F, Milione M. Kankava K, et al. Among authors: pisa e. J Neuroendocrinol. 2021 Aug;33(8):e13000. doi: 10.1111/jne.13000. Epub 2021 Jul 16. J Neuroendocrinol. 2021. PMID: 34268808 Free article.
Updates in classification of gastro-entero-pancreatic neuroendocrine neoplasms better reflect the biological characteristics of these tumours. ...
Updates in classification of gastro-entero-pancreatic neuroendocrine neoplasms better reflect the biological characteristics of these …
45 results